• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用机器学习对射血分数保留型心力衰竭进行表型分组分类。

Heart failure with preserved ejection fraction phenogroup classification using machine learning.

机构信息

Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.

Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

ESC Heart Fail. 2023 Jun;10(3):2019-2030. doi: 10.1002/ehf2.14368. Epub 2023 Apr 12.

DOI:10.1002/ehf2.14368
PMID:37051638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10192264/
Abstract

AIMS

Heart failure (HF) with preserved ejection fraction (HFpEF) is a complex syndrome with a poor prognosis. Phenotyping is required to identify subtype-dependent treatment strategies. Phenotypes of Japanese HFpEF patients are not fully elucidated, whose obesity is much less than Western patients. This study aimed to reveal model-based phenomapping using unsupervised machine learning (ML) for HFpEF in Japanese patients.

METHODS AND RESULTS

We studied 365 patients with HFpEF (left ventricular ejection fraction >50%) as a derivation cohort from the Nara Registry and Analyses for Heart Failure (NARA-HF), which registered patients with hospitalization by acute decompensated HF. We used unsupervised ML with a variational Bayesian-Gaussian mixture model (VBGMM) with common clinical variables. We also performed hierarchical clustering on the derivation cohort. We adopted 230 patients in the Japanese Heart Failure Syndrome with Preserved Ejection Fraction Registry as the validation cohort for VBGMM. The primary endpoint was defined as all-cause death and HF readmission within 5 years. Supervised ML was performed on the composite cohort of derivation and validation. The optimal number of clusters was three because of the probable distribution of VBGMM and the minimum Bayesian information criterion, and we stratified HFpEF into three phenogroups. Phenogroup 1 (n = 125) was older (mean age 78.9 ± 9.1 years) and predominantly male (57.6%), with the worst kidney function (mean estimated glomerular filtration rate 28.5 ± 9.7 mL/min/1.73 m ) and a high incidence of atherosclerotic factor. Phenogroup 2 (n = 200) had older individuals (mean age 78.8 ± 9.7 years), the lowest body mass index (BMI; 22.78 ± 3.94), and the highest incidence of women (57.5%) and atrial fibrillation (56.5%). Phenogroup 3 (n = 40) was the youngest (mean age 63.5 ± 11.2) and predominantly male (63.5 ± 11.2), with the highest BMI (27.46 ± 5.85) and a high incidence of left ventricular hypertrophy. We characterized these three phenogroups as atherosclerosis and chronic kidney disease, atrial fibrillation, and younger and left ventricular hypertrophy groups, respectively. At the primary endpoint, Phenogroup 1 demonstrated the worst prognosis (Phenogroups 1-3: 72.0% vs. 58.5% vs. 45%, P = 0.0036). We also successfully classified a derivation cohort into three similar phenogroups using VBGMM. Hierarchical and supervised clustering successfully showed the reproducibility of the three phenogroups.

CONCLUSIONS

ML could successfully stratify Japanese HFpEF patients into three phenogroups (atherosclerosis and chronic kidney disease, atrial fibrillation, and younger and left ventricular hypertrophy groups).

摘要

目的

射血分数保留的心力衰竭(HFpEF)是一种预后不良的复杂综合征。需要表型分析来确定基于亚型的治疗策略。日本 HFpEF 患者的表型尚未完全阐明,其肥胖程度远低于西方患者。本研究旨在使用无监督机器学习(ML)揭示日本 HFpEF 患者的基于模型的表型映射。

方法和结果

我们研究了来自奈良登记和心力衰竭分析(NARA-HF)的 365 名 HFpEF(左心室射血分数>50%)患者作为推导队列,该登记通过急性失代偿性心力衰竭住院的患者。我们使用带有常见临床变量的变分贝叶斯-高斯混合模型(VBGMM)进行无监督 ML。我们还对推导队列进行了层次聚类。我们采用日本心力衰竭综合征伴射血分数保留登记处的 230 名患者作为 VBGMM 的验证队列。主要终点定义为 5 年内全因死亡和 HF 再入院。在推导和验证的综合队列上进行了有监督 ML。由于 VBGMM 和最小贝叶斯信息准则的可能分布,最佳聚类数为 3,我们将 HFpEF 分为三个表型组。表型组 1(n=125)年龄较大(平均年龄 78.9±9.1 岁),主要为男性(57.6%),肾功能最差(平均估算肾小球滤过率 28.5±9.7mL/min/1.73m ),动脉粥样硬化因素发生率高。表型组 2(n=200)患者年龄较大(平均年龄 78.8±9.7 岁),BMI 最低(22.78±3.94),女性(57.5%)和心房颤动(56.5%)发生率最高。表型组 3(n=40)是最年轻的(平均年龄 63.5±11.2 岁),主要为男性(63.5±11.2 岁),BMI 最高(27.46±5.85),左心室肥厚发生率高。我们将这三个表型组分别定义为动脉粥样硬化和慢性肾脏病、心房颤动以及年轻和左心室肥厚组。在主要终点,表型组 1 表现出最差的预后(表型组 1-3:72.0% vs. 58.5% vs. 45%,P=0.0036)。我们还使用 VBGMM 成功地将推导队列分为三个类似的表型组。层次聚类和有监督聚类成功地显示了三个表型组的可重复性。

结论

ML 可以成功地将日本 HFpEF 患者分为三个表型组(动脉粥样硬化和慢性肾脏病、心房颤动以及年轻和左心室肥厚组)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/7d47719aace5/EHF2-10-2019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/e6cd8804a10e/EHF2-10-2019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/db6928ae9f4a/EHF2-10-2019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/cd96b0ef280b/EHF2-10-2019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/7d47719aace5/EHF2-10-2019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/e6cd8804a10e/EHF2-10-2019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/db6928ae9f4a/EHF2-10-2019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/cd96b0ef280b/EHF2-10-2019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f099/10192264/7d47719aace5/EHF2-10-2019-g004.jpg

相似文献

1
Heart failure with preserved ejection fraction phenogroup classification using machine learning.采用机器学习对射血分数保留型心力衰竭进行表型分组分类。
ESC Heart Fail. 2023 Jun;10(3):2019-2030. doi: 10.1002/ehf2.14368. Epub 2023 Apr 12.
2
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.基于机器学习的无监督聚类分析对射血分数保留心力衰竭患者的表型分析。
Eur J Heart Fail. 2020 Jan;22(1):148-158. doi: 10.1002/ejhf.1621. Epub 2019 Oct 21.
3
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组:详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.
4
Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction.具有射血分数保留的心力衰竭的不同表型群的特征、预后和治疗反应。
Int J Cardiol. 2021 Jan 15;323:148-154. doi: 10.1016/j.ijcard.2020.08.065. Epub 2020 Aug 26.
5
Relationship of interleukin-16 with different phenogroups in acute heart failure with preserved ejection fraction.白细胞介素-16 与射血分数保留的急性心力衰竭不同表型群的关系。
ESC Heart Fail. 2024 Aug;11(4):2354-2365. doi: 10.1002/ehf2.14808. Epub 2024 Apr 30.
6
Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes.临床表型分组比左心室射血分数分类更能有效分层心力衰竭结局。
ESC Heart Fail. 2021 Aug;8(4):2741-2754. doi: 10.1002/ehf2.13344. Epub 2021 May 2.
7
The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profiles.HFA-PEFF 评分可识别与不同生物标志物特征相关的“早期-HFpEF”表型群。
ESC Heart Fail. 2022 Jun;9(3):2032-2036. doi: 10.1002/ehf2.13861. Epub 2022 Mar 17.
8
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.利用机器学习鉴定射血分数保留型心力衰竭的新型表型组。
Heart. 2020 Mar;106(5):342-349. doi: 10.1136/heartjnl-2019-315481. Epub 2020 Jan 7.
9
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data.利用电子健康记录数据对射血分数保留或轻度降低的心衰进行表型分组。
BMC Cardiovasc Disord. 2024 Jul 5;24(1):343. doi: 10.1186/s12872-024-03987-9.
10
Differences in Cardiac Mechanics and Exercise Physiology Among Heart Failure With Preserved Ejection Fraction Phenomapping Subgroups.射血分数保留心力衰竭表型亚组中心脏力学和运动生理学的差异。
Am J Cardiol. 2023 Apr 15;193:102-110. doi: 10.1016/j.amjcard.2022.12.027. Epub 2023 Mar 7.

引用本文的文献

1
Clinical Usefulness of Right Ventricular-Pulmonary Artery Coupling in Patients with Heart Failure.右心室-肺动脉耦合在心力衰竭患者中的临床应用价值
Diagnostics (Basel). 2025 Aug 20;15(16):2083. doi: 10.3390/diagnostics15162083.
2
Development and validation of risk stratification and shared decision-making tool for catheter ablation for atrial fibrillation in patients with heart failure: a multicentre cohort study.心力衰竭患者心房颤动导管消融风险分层与共同决策工具的开发与验证:一项多中心队列研究
EClinicalMedicine. 2025 Apr 28;83:103219. doi: 10.1016/j.eclinm.2025.103219. eCollection 2025 May.
3
Sex differences in the association between nutritional status and in-hospital mortality in HFpEF patients.

本文引用的文献

1
Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF.机器学习定义射血分数保留的心力衰竭住院患者的表型和结局:来自 ASCEND-HF 的结果。
Am Heart J. 2022 Dec;254:112-121. doi: 10.1016/j.ahj.2022.08.009. Epub 2022 Aug 23.
2
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.勘误:《2021欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗指南》:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组制定,并得到了ESC心力衰竭协会(HFA)的特别贡献。
Eur Heart J. 2021 Dec 21;42(48):4901. doi: 10.1093/eurheartj/ehab670.
3
射血分数保留的心力衰竭(HFpEF)患者营养状况与院内死亡率之间关联的性别差异。
ESC Heart Fail. 2025 Aug;12(4):2499-2506. doi: 10.1002/ehf2.15332. Epub 2025 May 21.
4
Neuron-non-neuron electrical coupling networks are involved in chronic stress-induced electrophysiological changes in lateral habenular neurons.神经元-非神经元电耦合网络参与慢性应激诱导的外侧缰核神经元电生理变化。
J Physiol. 2025 May;603(9):2713-2740. doi: 10.1113/JP287286. Epub 2025 Apr 1.
5
Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Study.射血分数保留的心力衰竭从急性期到稳定期的表型轨迹:来自PURSUIT-HFpEF研究的见解
J Am Heart Assoc. 2025 Feb 4;14(3):e037567. doi: 10.1161/JAHA.124.037567. Epub 2025 Feb 3.
6
Machine learning in predicting heart failure survival: a review of current models and future prospects.机器学习在预测心力衰竭生存率中的应用:当前模型与未来展望综述
Heart Fail Rev. 2025 Mar;30(2):431-442. doi: 10.1007/s10741-024-10474-y. Epub 2024 Dec 10.
7
Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data.基于血常规和生化检测数据构建心血管多病种的机器学习诊断模型。
Cardiovasc Diabetol. 2024 Sep 28;23(1):351. doi: 10.1186/s12933-024-02439-0.
8
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭的独特特征和新的药理学靶点
Rev Cardiovasc Med. 2024 Jul 23;25(7):270. doi: 10.31083/j.rcm2507270. eCollection 2024 Jul.
9
Clinical phenotypes of heart failure patients with supranormal ejection fraction.射血分数正常高值的心力衰竭患者的临床表型
ESC Heart Fail. 2024 Dec;11(6):4160-4171. doi: 10.1002/ehf2.15021. Epub 2024 Aug 12.
10
Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1.急性失代偿性心力衰竭充血缓解研究的患者选择与终点定义:第1部分。
J Soc Cardiovasc Angiogr Interv. 2023 Aug 8;2(6Part B):101060. doi: 10.1016/j.jscai.2023.101060. eCollection 2023 Nov-Dec.
Phenotyping heart failure using model-based analysis and physiology-informed machine learning.基于模型分析和生理学启发的机器学习对心力衰竭进行表型分析。
J Physiol. 2021 Nov;599(22):4991-5013. doi: 10.1113/JP281845. Epub 2021 Oct 18.
4
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
5
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.射血分数保留的心力衰竭的全球差异:PARAGON-HF 试验。
Circ Heart Fail. 2021 Apr;14(4):e007901. doi: 10.1161/CIRCHEARTFAILURE.120.007901. Epub 2021 Apr 19.
6
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较:CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
7
Trajectory Generation by Chance-Constrained Nonlinear MPC With Probabilistic Prediction.基于概率预测的机会约束非线性 MPC 的轨迹生成。
IEEE Trans Cybern. 2021 Jul;51(7):3616-3629. doi: 10.1109/TCYB.2020.3032711. Epub 2021 Jun 23.
8
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.心肌基因表达特征在射血分数保留的心力衰竭患者中。
Circulation. 2021 Jan 12;143(2):120-134. doi: 10.1161/CIRCULATIONAHA.120.050498. Epub 2020 Oct 29.
9
Dapagliflozin in Patients with Chronic Kidney Disease.达格列净治疗慢性肾脏病患者。
N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
10
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组:详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.